0 NASDAQ Companies - September 4, 2019Tonix Pharmaceuticals Doses Participants in Phase 1 Study Evaluating TNX-601 for the Daytime Treatment of Posttraumatic Stress DisorderRead More
0 NASDAQ Companies - September 4, 2019Fulcrum Therapeutics Appoints Pamela Strode, Seasoned Industry Executive, to Lead Regulatory Affairs TeamRead More
0 NASDAQ Companies - September 4, 2019Orchard Therapeutics Presents an Integrated Data Analysis Demonstrating Sustained Clinical Benefit of OTL-200 for the Treatment of Metachromatic LeukodystrophyRead More
0 NASDAQ Companies - September 4, 2019Cyclacel Pharmaceuticals to Present at the 21st Annual H.C. Wainwright Global Investment Conference Read More
0 NASDAQ Companies - September 4, 2019Auris Medical Announces Appointment of New Chief Financial OfficerRead More
0 NASDAQ Companies - September 4, 2019Summit Therapeutics to Participate in Upcoming Investor ConferencesRead More
0 NASDAQ Companies - September 4, 2019Prevail Therapeutics to Present at Morgan Stanley 2019 Global Healthcare ConferenceRead More
0 NASDAQ Companies - September 4, 2019Plug Power Supports Increase in MEA-Production Demand with Facility Expansion in Rochester, New YorkRead More
0 TSX News - September 4, 2019Aleafia Health Expands Outdoor Cannabis Facility by Additional 60 Acres with Property AcquisitionRead More
0 TSX News - September 4, 2019Goodfood’s Active Subscribers Count Reaches the 200,000 Mark With an Increase of 125% Year-Over-YearRead More
